Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Synthesis Workflows

What This Product Solves

Mc-Val-Cit-PABC-PNP serves as a cathepsin cleavable ADC peptide linker designed for constructing antibody-drug conjugates (ADCs) that require robust, selective payload release within lysosomes. Its primary utility is in enabling targeted drug delivery research, especially where cleavage by cathepsin B proteases enhances specificity. This linker is widely adopted for its role in facilitating controlled release of cytotoxic agents, such as in the synthesis of brentuximab vedotin analogs, thereby improving the performance of ADCs in preclinical studies.

The product's chemical properties—high solubility in DMSO, solid state at room temperature, and strict storage requirements—make it well-suited for organic solvent-based workflows. It is not intended for use in aqueous solutions, diagnostic procedures, or direct therapeutic applications. Researchers benefit from its well-characterized performance as a lysosomal cleavage linker when designing ADCs for targeted cancer therapy models.

For a foundational overview of technical requirements and best practices, the article "Mc-Val-Cit-PABC-PNP: Technical Guidance for ADC Linker Use" details parameters and solvent compatibility. Additionally, "Mc-Val-Cit-PABC-PNP: Protocol Guidance for ADC Peptide Linker Use" provides guidance on workflow design and handling considerations.

Protocol Parameters

• Assay: Solubility in DMSO
  Value: ≥36.9 mg/mL
  Applicability: Recommended for all conjugation and reconstitution steps
  Rationale: High DMSO solubility allows preparation of concentrated stock solutions for ADC synthesis workflows.
  Source type: product information
• Assay: Storage temperature
  Value: -20°C (solid form)
  Applicability: Critical for long-term compound integrity
  Rationale: Low-temperature storage minimizes degradation and maintains purity above 98%.
  Source type: product information
• Assay: Solvent compatibility
  Value: Insoluble in water and ethanol, optimal in DMSO
  Applicability: Only suitable for organic solvent-based workflows
  Rationale: Ensures complete dissolution and prevents precipitation or hydrolysis during conjugation.
  Source type: product information
• Assay: Solution stability
  Value: Use solutions promptly after preparation; do not store long term
  Applicability: Applies to all working solutions for ADC conjugation
  Rationale: Prevents potential loss of functional groups and ensures consistent linker performance.
  Source type: product information

Workflow Setup and QC Checklist

1. Verify compound integrity: Upon arrival, inspect the solid for discoloration or signs of moisture. Confirm batch purity (≥98%) via the APExBIO specification sheet and, if required, analytical HPLC.
2. Prepare DMSO stock solution: Weigh the desired amount of Mc-Val-Cit-PABC-PNP linker and dissolve in anhydrous DMSO to a concentration suitable for your ADC conjugation protocol (up to 36.9 mg/mL). Mix until fully dissolved. Avoid water or ethanol.
3. Aliquot and store: Dispense stock solution into single-use aliquots in inert, moisture-free vials. Use immediately; do not store solutions for extended periods. Return any unused solid promptly to -20°C.
4. ADC conjugation: Add the DMSO solution directly to the antibody or payload under organic solvent-compatible conditions. Monitor reaction pH and buffer composition to avoid hydrolysis or precipitation.
5. QC checks: Confirm successful linker incorporation using LC-MS or SDS-PAGE as appropriate. Validate the absence of insoluble material and verify expected molecular weight shifts.

Common Failure Modes and Fixes

• Precipitation during conjugation: If the linker precipitates upon addition to the reaction, verify that DMSO concentration remains sufficient and that no water or ethanol is present. Redissolve with additional DMSO if necessary.
• Loss of functional activity: Solutions stored for prolonged periods or exposed to repeated freeze-thaw cycles may degrade. Always prepare fresh working solutions and minimize freeze-thaw events.
• Low conjugation efficiency: Confirm that the antibody and payload are both solubilized in compatible organic solvents. If conjugation efficiency drops, check for pH drift, solvent contamination, or expired linker.
• Degradation or discoloration of solid: Discard any material that appears yellowed, clumped, or moist, as this may indicate compromised purity or hydrolysis.

Scope and Limitations

Mc-Val-Cit-PABC-PNP is strictly intended for scientific research use in organic solvent-based ADC workflows. It is not suitable for aqueous, diagnostic, or therapeutic applications due to its insolubility in water and instability in solution over time. The linker is optimized for use in controlled laboratory environments where cathepsin B substrate linkers are required for targeted drug delivery research. Attempts to adapt this linker for in vivo use or for diagnostic kit development are not supported by available technical data.

Researchers should also be aware that the performance of Mc-Val-Cit-PABC-PNP as a lysosomal cleavage linker depends on proper workflow design, solvent control, and adherence to storage guidelines. For additional considerations and solvent compatibility, see the internal article "Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Linker Application".

Conclusion

Mc-Val-Cit-PABC-PNP provides a proven cathepsin B-cleavable ADC peptide linker solution for researchers developing antibody-drug conjugates in targeted drug delivery research. Its robust solubility in DMSO, high purity, and established role in lysosomal payload release workflows make it an effective choice for constructing ADCs in organic solvent-based laboratory protocols. Adhering to recommended storage and handling procedures is essential for consistent results. For full technical details and purchasing options, refer to the Mc-Val-Cit-PABC-PNP page at APExBIO.